SEP 29, 2019 2:57 PM PDT

CBD Alleviates Angelman Syndrome Seizures in Mice Trial

WRITTEN BY: Julia Travers

CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurological condition?

Cannabidiol (CBD) can lessen seizure severity in mice that genetically model Angelman syndrome, a rare neurodevelopmental condition. This condition is characterized by brain rhythm dysfunction, intellectual disability, lack of speech and, in many cases, drug-resistant epilepsy. The effectiveness of CBD was tested by University of North Carolina at Chapel Hill (UNC) School of Medicine researchers.

In the lab of Ben Philpot, the team tested the effects of CBD on seizures, brain activity abnormalities and motor deficit in mice that genetically model Angelman syndrome. According to EurekAlert, the Philpot lab creates genetically modified mouse models of neurodevelopmental disorders and uses them to look for new treatments for diseases including Rett, Pitt-Hopkins and Angelman syndromes.

One injection of CBD was found to substantially lessen seizure severity, when the seizures were triggered by loud sound or elevated body temperature. A typical dose of 100 mg/kg of CBD did lead to mild mouse sedation, but it had minimal impact on their balance or coordination. And, CBD reinstituted normal brain rhythms.

"We're confident our study provides the preclinical framework necessary to better guide the rational development of CBD as a therapy to help lessen seizures associated with Angelman syndrome and other neurodevelopmental disorders," Bin Gu, PhD, first author and postdoctoral fellow in the Philpot lab, said.

"There is an unmet need for better treatments for kids with Angelman syndrome to help them live fuller lives and to aid their families and caregivers. Our results show CBD could help the medical community safely meet this need," Ben Philpot, PhD, said.

 

“Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice,” was published in the Journal of Clinical Investigation.

 

Article Source: EurekAlert, Journal of Clinical Investigation

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUN 08, 2021
Health & Medicine
THC Level in Body Fluids Is Not a Good Marker of Impairment
JUN 08, 2021
THC Level in Body Fluids Is Not a Good Marker of Impairment
It’s not easy to tell how impaired a person will be based on how much THC they have in their body a study has foun ...
AUG 05, 2021
Health & Medicine
Health Professionals Working with Cystic Fibrosis Patients Lack Cannabis Confidence
AUG 05, 2021
Health Professionals Working with Cystic Fibrosis Patients Lack Cannabis Confidence
The quality of dialogue and understanding that clinical healthcare and social care workers have around cannabis and cyst ...
AUG 13, 2021
Health & Medicine
15% of Employees Have Worked From Home While High
AUG 13, 2021
15% of Employees Have Worked From Home While High
Working from home became a huge (and successful) trend during the pandemic, and even with communities now re-opening, ma ...
AUG 18, 2021
Cannabis Sciences
Cancer Patients Use Less Cannabis than General Public
AUG 18, 2021
Cancer Patients Use Less Cannabis than General Public
Despite increasing legalization for recreational cannabis across the US, cancer patients have largely abstained from usi ...
OCT 28, 2021
Cannabis Sciences
RIP Indica/Sativa Cannabis Distinction - Trick, Treat, or Terpene?
OCT 28, 2021
RIP Indica/Sativa Cannabis Distinction - Trick, Treat, or Terpene?
For years, Cannabis growers, breeders, and users have distinguished cultivars using vernacular Sativa/Indica labels. Wit ...
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
Loading Comments...